Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.

作者: MA Westerink , Harry W Schroeder Jr , Moon H Nahm , None

DOI:

关键词:

摘要: Streptococcus pneumoniae is a significant human pathogen and currently available pneumococcal vaccines are designed to elicit anti-capsule antibodies. The 23-valent polysaccharide vaccine has been used in older adults for many years whereas 7-, 10-, 13-valent conjugate have only commonly young children the last decade. In addition their high protective efficacy among children, use of had number additional effects, including production serotype shift providing new herd immunity adults. immunogenicity both these types can be determined by using an ELISA assay measure antibody levels or opsonophagocytosis assess opsonic function. As assays improved over time, awareness analytical limitations studies grown. While effective adults, it less elderly Aging-associated ineffectiveness may due aging-dependent changes repertoire and/or reduction IgM associated with B cell subpopulations. immunologic basis aging-associated immune defects thus remains active area research.

参考文章(206)
Fein Am, Niederman Ms, Feinsilver Sh, Atypical manifestations of pneumonia in the elderly. Clinics in Chest Medicine. ,vol. 12, pp. 319- 336 ,(1991)
Styrt B, Infection associated with asplenia: risks, mechanisms, and prevention. The American Journal of Medicine. ,vol. 88, ,(1990)
J Pekka Nuorti, Cynthia G Whitney, Prevention of pneumococcal disease among infants and children: use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. ,vol. 59, pp. 1- 18 ,(2010)
Tomi Wuorimaa, Immunogenicity and tolerability of an 11-valent pneumococcal conjugate vaccine National Public Health Institute. ,(2001)
Dino Veneri, Giuseppe Tridente, Riccardo Ortolani, Antonio Vella, Massimo Franchini, Giovanni Pizzolo, Expression of CD27 and CD23 on peripheral blood B lymphocytes in humans of different ages. Vox Sanguinis. ,vol. 7, pp. 29- 34 ,(2009) , 10.2450/2008.0007-08
R Andrew Moore, Philip J Wiffen, Benjamin A Lipsky, Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials BMC Family Practice. ,vol. 1, pp. 1- 10 ,(2000) , 10.1186/1471-2296-1-1
Yuhui Shi, Takashi Yamazaki, Yoshio Okubo, Yoshio Uehara, Kazuo Sugane, Kazunaga Agematsu, Regulation of Aged Humoral Immune Defense against Pneumococcal Bacteria by IgM Memory B Cell The Journal of Immunology. ,vol. 175, pp. 3262- 3267 ,(2005) , 10.4049/JIMMUNOL.175.5.3262
John F. Bohnsack, Harry R. Hill, Howard V. Raff, Shyh Dar Shyur, Douglas K. Kelsey, Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B streptococci. Journal of Immunology. ,vol. 148, pp. 1879- 1884 ,(1992)
K. F. Schäble, D. L. Crimmins, D. W. Mccourt, M. G. Scott, Gookhyun Chung, M. H. Nahm, H. G. Zachau, E.-M. Quenzel, R. Thiebe, Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. IV. The less frequently expressed VL are heterogeneous. Journal of Immunology. ,vol. 147, pp. 4007- 4013 ,(1991)